article thumbnail

Univ. of Wash.-spinout Icosavax raises $100M to fund vaccine development technology

GeekWire

Icosavax creates virus-like particles with technology licensed from the University of Washington’s Institute for Protein Design. Simpson was formerly the CEO of PvP Biologics, another IPD spinout, which he oversaw from the company’s launch through its sale to the pharmaceutical company Takeda. Icosavax Photo).

article thumbnail

Tech Moves: Top Blue Origin engineer joins SpaceX; Axon hires HTC Vive exec; Porch adds to board

GeekWire

Eby has been succeeded by Morgan Hellar who originally joined WRF in 2004 as a license administrator for the organization’s patent portfolio. Portland-based Sparrow Pharmaceuticals appointed Frank Czerwiec as chief medical officer and Jamie MacPherson as VP of regulatory affairs and quality. Saty Bahadur. Upwork Photo).

CTO Hire 137
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ireland’s status as tax haven for tech firms like Google, Facebook, and Apple is ending

The Verge

This is a major shift for the country that is the European headquarters for many large US pharmaceutical companies, as well as tech firms, including Google, Apple, and Facebook. Companies typically create Irish subsidiaries of their companies that license their intellectual property, on which the subsidiary pays royalties.

Google 128
article thumbnail

Seattle-based Icosavax, which is developing COVID-19 vaccines, files for IPO 4 years after launch

GeekWire

Icosavax creates virus-like particles with technology licensed from the University of Washington’s Institute for Protein Design. Founder and CEO Adam Simpson formerly led another IPD spinout, PvP Biologics, which sold to the pharmaceutical company Takeda. Icosavax Photo).

article thumbnail

Alpine raises $91M to fuel the Seattle biotech’s clinical trials for lupus and cancer

GeekWire

That payment is part of a licensing deal inked last year with the pharmaceutical giant for clinical testing of another immune-modulating agent, ALPN-101, for lupus. Alpine’s phase 2 trial for ALPN-101 is ongoing. The company’s research and development expenses reached $14.6

article thumbnail

Get the scoop on the Mars Society’s plan to establish a tech institute, maybe in Seattle

GeekWire

” The Mars Technology Institute would focus on three tech frontiers: Biotech innovations that could maximize the prospects for producing food, pharmaceuticals and other supplies using Martian resources. . “What is needed is an institution devoted to developing the technologies that will allow us to live once we are there.”

Nonprofit 145
article thumbnail

Seattle-area psychedelics startup CaaMTech raises $22M to advance to human testing

GeekWire

Where scheduling is involved, we always stay within the bounds of labs that are licensed for handling.” The company has four employees and plans to hire experts in advanced drug development and pharmaceutical regulatory processes. Other compounds are sourced as chemical standards from commercial chemical suppliers.

Chemicals 145